Table of Contents

1. Introduction

1.1 Market Definition

1.2 Scope

1.3 Research Assumptions

2. Research Methodology

3. Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

4. Impact Analysis

4.1 COVID-19 Impact Analysis

4.2 Impact of Ukraine- Russia war

4.3 Impact of ongoing Recession

4.3.1 Introduction

4.3.2 Impact on major economies

4.3.2.1 US

4.3.2.2 Canada

4.3.2.3 Germany

4.3.2.4 France

4.3.2.5 United Kingdom

4.3.2.6 China

4.3.2.7 Japan

4.3.2.8 South Korea

4.3.2.9 Rest of the World

5. Value Chain Analysis

6. Porter’s 5 forces model

7.  PEST Analysis

8. Point of Care Diagnostics/Testing Market, by End User

8.1 Hospitals & Clinics

8.2 Diagnostic Centers

8.3 Homecare/Self Testing

8.4 Others

9. Point of Care Diagnostics/Testing Market, by Mode of Purchase

9.1 OTC Testing Products

9.2 Prescription-based testing products

10. Point of Care Diagnostics/Testing Market, by Platform

10.1 Immunoassays

10.2 Molecular Diagnostics

10.3 Dipsticks

10.4 Others

11. Point of Care Diagnostics/Testing Market, by Product

11.1 Glucose Monitoring

11.2 Cardiometabolic Monitoring

11.3 Infectious Disease Testing

11.4 Coagulation Monitoring

11.5 Pregnancy & Fertility Testing

11.6 Hematology Testing

11.7 Cancer/Tumor Marker Testing

11.8 Urinalysis Testing

11.9 Cholesterol

11.10 Drugs-of-Abuse Testing

11.11 Others

12. Regional Analysis

12.1 Introduction

12.2 North America

12.2.1 USA

12.2.2 Canada

12.2.3 Mexico

12.3 Europe

12.3.1 Germany

12.3.2 UK

12.3.3 France

12.3.4 Italy

12.3.5 Spain

12.3.6 The Netherlands

12.3.7 Rest of Europe

12.4 Asia-Pacific

12.4.1 Japan

12.4.2 South Korea

12.4.3 China

12.4.4 India

12.4.5 Australia

12.4.6 Rest of Asia-Pacific

12.5 The Middle East & Africa

12.5.1 Israel

12.5.2 UAE

12.5.3 South Africa

12.5.4 Rest

12.6 Latin America

12.6.1 Brazil

12.6.2 Argentina

12.6.3 Rest of Latin America

13. Company Profiles

13.1 Hoffmann-La Roche Ltd

13.1.1 Financial

13.1.2 Products/ Services Offered

13.1.3 SWOT Analysis

13.1.4 The SNS view

13.2 Johnson & Johnson Services, Inc.

13.3 PTS Diagnostics

13.4 Nova Biomedical

13.5 QuidelCorporation

13.6 Abbott Laboratories

13.7 Siemens Healthineers GmbH

13.8 Chembio Diagnostics, Inc.

13.9 Becton, Dickinson, and Company

13.10 Danaher Corporation

14. Competitive Landscape

14.1 Competitive Benchmarking

14.2 Market Share Analysis

14.3 Recent Developments

15. Conclusion